36 related articles for article (PubMed ID: 29618765)
21. Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.
Park S; Shimizu C; Shimoyama T; Takeda M; Ando M; Kohno T; Katsumata N; Kang YK; Nishio K; Fujiwara Y
Breast Cancer Res Treat; 2006 Sep; 99(1):9-17. PubMed ID: 16752223
[TBL] [Abstract][Full Text] [Related]
22. OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
Li XP; Lan JY; Liu DQ; Zhou H; Qian MM; Wang WW; Yang M
Gene; 2018 Apr; 651():161-165. PubMed ID: 29409738
[TBL] [Abstract][Full Text] [Related]
23. ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis.
Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Expósito-Ruiz M; Calleja-Hernández MÁ
Surg Oncol; 2017 Dec; 26(4):473-482. PubMed ID: 29113667
[TBL] [Abstract][Full Text] [Related]
24. [Drug resistance mediated by ABC transporters].
Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
[TBL] [Abstract][Full Text] [Related]
26. Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS).
Kim JE; Choi J; Park J; Park C; Lee SM; Park SE; Song N; Chung S; Sung H; Han W; Lee JW; Park SK; Kim MK; Noh DY; Yoo KY; Kang D; Choi JY
Pharmacogenomics J; 2018 Sep; 18(5):633-645. PubMed ID: 29618765
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
Huang Y
Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
[TBL] [Abstract][Full Text] [Related]
28. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
Joyce H; McCann A; Clynes M; Larkin A
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
[TBL] [Abstract][Full Text] [Related]
29. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment.
Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
Cancer Treat Rev; 2009 Feb; 35(1):18-31. PubMed ID: 18771857
[TBL] [Abstract][Full Text] [Related]
30. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
31. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.
Gerloff T
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):69-77. PubMed ID: 14598019
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
